News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,153 Results
Type
Article (13971)
Company Profile (304)
Press Release (247878)
Section
Business (79447)
Career Advice (151)
Deals (13199)
Drug Delivery (34)
Drug Development (50418)
Employer Resources (32)
FDA (5695)
Job Trends (5122)
News (144343)
Policy (10032)
Tag
Academia (902)
Alliances (21554)
Alzheimer's disease (756)
Approvals (5674)
Artificial intelligence (68)
Bankruptcy (97)
Best Places to Work (4527)
Biotechnology (249)
Breast cancer (112)
Cancer (891)
Cardiovascular disease (71)
Career advice (132)
CAR-T (73)
Cell therapy (217)
Clinical research (40210)
Collaboration (309)
Compensation (128)
COVID-19 (1006)
C-suite (78)
Cystic fibrosis (66)
Data (984)
Diabetes (85)
Diagnostics (1207)
Drug discovery (56)
Earnings (29020)
Events (47268)
Executive appointments (248)
FDA (6061)
Funding (306)
Gene editing (63)
Gene therapy (163)
GLP-1 (310)
Government (1066)
Healthcare (6548)
Infectious disease (1043)
Inflammatory bowel disease (98)
IPO (7200)
Job creations (860)
Job search strategy (127)
Layoffs (189)
Legal (1375)
Lung cancer (130)
Lymphoma (62)
Manufacturing (86)
Medical device (2562)
Medtech (2563)
Mergers & acquisitions (6134)
Metabolic disorders (257)
Neuroscience (999)
NextGen Class of 2024 (2007)
Non-profit (847)
Northern California (1091)
Obesity (140)
Opinion (92)
Parkinson's disease (75)
Patents (61)
People (25143)
Phase I (14198)
Phase II (18671)
Phase III (11831)
Pipeline (367)
Postmarket research (859)
Preclinical (5985)
Radiopharmaceuticals (205)
Rare diseases (201)
Real estate (1411)
Regulatory (8294)
Research institute (931)
Southern California (976)
Startups (1966)
United States (8668)
Vaccines (164)
Weight loss (83)
Date
Last 7 days (365)
Last 30 days (1412)
Last 365 days (20552)
2024 (20464)
2023 (22436)
2022 (26857)
2021 (27838)
2020 (23388)
2019 (16245)
2018 (11759)
2017 (13767)
2016 (11868)
2015 (14378)
2014 (10412)
2013 (7504)
2012 (7547)
2011 (7642)
2010 (7449)
Location
Africa (147)
Asia (16967)
Australia (2859)
California (2474)
Canada (809)
China (204)
Colorado (92)
Connecticut (109)
Europe (36515)
Florida (271)
Georgia (71)
Illinois (153)
Indiana (63)
Kansas (55)
Maryland (330)
Massachusetts (1957)
Minnesota (101)
New Jersey (630)
New York (683)
North Carolina (419)
Northern California (1091)
Ohio (82)
Pennsylvania (475)
South America (209)
Southern California (976)
Texas (278)
Washington State (247)
262,153 Results for "prota therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Prota Therapeutics’ CEO Mimi Tang honoured at BioMelbourne Network’s Women in Leadership Awards 2024
Prota Therapeutics ' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards.
April 29, 2024
·
4 min read
Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments
Prota Therapeutics Pty Ltd today announced financing of US$21 million in equity and debt financing.
January 16, 2024
·
4 min read
Drug Development
Global Roundup: Prota’s Immunotherapy Shows Success Against Peanut Allergy
In a Phase IIb study, data showed that Prota Therapeutics’ oral immunotherapy led to 51% of children reaching clinical remission of their peanut allergy compared to placebo. See inside for this and more!
May 18, 2022
·
8 min read
·
Alex Keown
Drug Development
Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients
Prota Therapeutics, an Australian biotechnology company focused on the development of novel oral immunotherapy treatments, has achieved a significant milestone in the treatment of peanut allergy in children.
February 9, 2022
·
6 min read
Prota Therapeutics Achieves 51 Percent Peanut Allergy Remission Rate, First Company to Validate Significant Quality of Life Improvements Compared with Standard Care
Prota Therapeutics Pty Ltd is the first company to validate significant Health-Related Quality of Life improvements, when compared to placebo, in a Phase 2b clinical trial of oral immunotherapy PRT120, in which 51 percent of treated children aged 1-10 years achieved clinical remission.
May 16, 2022
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Avenzo Therapeutics Announces Appointment of Patrick Machado, J.D. to Board of Directors as Independent Director
November 20, 2024
·
2 min read
Press Releases
Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025
December 19, 2024
·
2 min read
Press Releases
Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
November 6, 2024
·
1 min read
Press Releases
Protagonist Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference 2024
November 22, 2024
·
2 min read
1 of 26,216
Next
